StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CVS

CVS Health Corporation

CVS NYSE Retail-Drug Stores and Proprietary Stores EDGAR ↗
$104.42
-0.95 -0.90%

Key statistics

from XBRL data in SEC filings
Market cap
$134B
Revenue (TTM)
$415B
Net income (TTM)
$4.89B
EPS (TTM)
$3.79
P/E ratio
27.6
Dividend yield
2.55%
Free cash flow
$7.81B
Cash
$11.3B
Total assets
$254B
Gross margin
7.1%
52-week range
$61.35 – $110.68

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Aug 5, 2026 8-K Results of operations (earnings release) Aug 5, 2026 8-K Director or officer change; Shareholder vote results May 18, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Director or officer change Mar 19, 2026 10-K Fiscal year ended 2025-12-31 Feb 10, 2026 8-K Results of operations (earnings release) Feb 10, 2026 8-K Regulation FD disclosure Dec 9, 2025 8-K Other events Nov 20, 2025 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Results of operations (earnings release) Oct 29, 2025 8-K Other events Sep 22, 2025 8-K Other events Aug 15, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release) Jul 31, 2025 8-K Shareholder vote results May 20, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 8-K Director or officer change; Regulation FD disclosure Apr 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 12, 2025 8-K Results of operations (earnings release) Feb 12, 2025 8-K Other events Dec 17, 2024 8-K Other events Dec 10, 2024 8-K Other events Dec 9, 2024 8-K Other events Dec 6, 2024 8-K Other events Dec 5, 2024 8-K Other events Dec 2, 2024 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Nov 18, 2024 8-K Director or officer change; Regulation FD disclosure Nov 6, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Oct 18, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Director or officer change; Shareholder vote results May 22, 2024 8-K Other events May 9, 2024 8-K Other events May 8, 2024 10-Q Quarter ended 2024-03-31 May 1, 2024 8-K Results of operations (earnings release) May 1, 2024